they said results were expected before end of calendar year in an investor preso, and in the ann. saying the first patient was dosed. I woudn't expect them to provide anything more specific than, end of 2024 I dont see what value it provides the company other than introducing a risk to miss it. Timelines, biotech, I am sure you know the challenge .
patient was dosed around October 3rd, with follow ups up to 90 days. Based on the timeline below, I expect the follow up period to have now just started. Unclear to me when data collection and analysis starts but could have easily missed something that makes it clear.
ILA Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
.
(20min delay)